Introduction
It has recently been shown that cellular proteins regulate HIV-1 replication. Interestingly, several studies of purified HIV-1 virions have shown that, in addition to proteins encoded by the virus, cellular proteins are taken into the virions [1] . Some of these proteins, such as cyclophilin A and lysyl-tRNA synthetase (LysRS), are packaged into virions as a result of their interaction with Pr55 gag or p160
gag-pol proteins during assembly [2] [3] [4] [5] . These cellular proteins play an important role in viral precursor protein folding and tRNA Lys3 packaging. Thus, understanding the packaging mechanism of cellular proteins is one way to elucidate the viral replication capacity. One of the critical events in HIV-1 replication is reverse transcription. Cellular tRNA Lys3 is required for the efficient initiation of reverse transcription and is selectively incorporated into viral particles during its assembly because the 3′ terminal 18 nucleotides must be hybridized to the primer-binding site of HIV-1 genome RNA as a replication primer [6] . Gabor et al. [7] reported that the elevated amount of packaged tRNA Lys3 increases viral infectivity. Efficient packaging of tRNA Lys3 is facilitated by interaction between Pr55 gag or p160 gag-pol has been known as a "moonlighting" protein. Several studies have shown that GAPDH is related to apoptosis, the exportation of nuclear RNA, and DNA repair. [10] . Furthermore, GAPDH regulates viral replication by binding to cis-acting viral RNAs, such as the hepatitis A virus, hepatitis C virus and human parainfluenza virus [11] [12] [13] . Similarly, we previously reported that GAPDH also plays a role in negatively regulating HIV-1 infection [14] . GAPDH is incorporated into virions via its interaction with Pr55 gag [14] . Increased GAPDH packaging efficiency decreases reverse transcription efficiency owing to the suppression of LysRS and tRNA Lys3 packaging [14] . Thus, the binding of GAPDH to Pr55 gag has an important role in the suppression of HIV-1 replication. These findings indicate that GAPDH negatively regulates HIV-1 replication and provide insights into a new host defense mechanism against HIV-1 infection. However, it is remains unclear which amino acid residues of GAPDH are important for the recognition of Pr55 
Materials and methods

Cell culture
TZM-bl cells, which were obtained from the NIH AIDS Research and Reference Reagent Program, and HEK293 cells were maintained at 37°C in DMEM supplemented with 10% fetal calf serum (FCS) containing 100 IU/ml penicillin and 100 μg/ml streptomycin in 5% CO 2 .
Viruses
The infectious molecular clone pNL-CH [15] , derived from the pNL4-3 clone of HIV-1, and each mutated GAPDH expression vector (cloned into the pcDNA3.1D/V5-His-TOPO ® vector) were cotransfected into HEK293 cells to prepare various GAPDH-mutant-packaging viruses. At 48 h post-cotransfection, the virus-containing supernatant was collected and clarified by filtration using 0.45-µm-pore-size filters [14] .
Plasmid
The coding region of the HIV-1 NL-CH protein and GAPDH was amplified by PCR using the following primers. 
Yeast two-hybrid analysis
The Matchmaker™ Gold Yeast Two-hybrid System (Clontech Laboratories, Inc.) was used in accordance with manufacturer's recommendations to analyze the interaction between several reconstructed GAPDH and HIV-1 proteins. Briefly, the bait (cloned into pGBKT7) and prey (cloned into pGADT7) constructs were cotransformed into Y2HGold and plated on QDO/X/A plates (without tryptophan leucine, adenine, and histidine and with aureobasidin A and X-α-Gal). As a positive or negative control, pGADT7-T and pGBKT7-53 or pGADT7 AD and pGBKT7 DNA-BD were cotransformed, respectively. To validate transformed protein expression, each yeast strain was lysed and detected using an anti-HA antibody (Wako Pure Chemical Industries, Ltd.) or an anti-c-Myc antibody (Clontech Laboratories, Inc.).
Coimmunoprecipitation
HEK293 cells transfected with each GAPDH expression vector were lysed and the lysate was used for coimmunoprecipitation, as a previously described [14] . Briefly, the precleaned lysate was incubated with an anti-V5 antibody (Thermo Fisher Scientific Inc.) or an isotype control mouse IgG antibody (R & D SYSTEMS, Inc.), and further incubated with µMACS™ Protein G MicroBeads (Miltenyi Biotec K.K.). The separated proteins were detected by western immunoblot analysis using the anti-GAPDH antibody (Santa Cruz Biotechnology, Inc.). To detect GAPDH interacting Pr55 gag , pNL-CH and WT or M6
GAPDH expression vector were cotransfected into HEK293 and the resulting lysate was incubated with an anti-GAPDH antibody before incubating with µMACS™ Protein G MicroBeads.
Measurement of tRNA Lys3 packaging levels in virions and
reverse transcription products tRNA Lys3 was prepared from various GAPDH mutants packaging viruses, as a previously described [14] . Briefly, tRNA Lys3 was collected from each virus and reverse-transcribed using a SuperScript™ III Firststrand Synthesis System (Thermo Fisher Scientific, Inc.). The packaging level of tRNA Lys3 was normalized by incorporated viral genomic RNA. The reverse transcription products were analyzed using previously described methods [14] . Total DNA from each virus infected TZM-bl cells was subjected to quantitative real-time PCR with primer pair specific for the R/U5 (early) region.
Results
C-terminal domain of GAPDH interacts with HIV-1 MA and CA
We previously demonstrated that GAPDH, which is expressed in HIV-1 producer cells, is incorporated into viral particles via its interaction with viral precursor proteins [14] . To further investigate which domain is required for the interactions, we prepared viral proteins-or GAPDH-expression vectors, and performed Y2H analysis. The Y2HGold yeast strain was cotransformed with the constructed bait ( gag . Furthermore, Y2H analysis using processing forms of Pr55 gag indicated that MA and CA-NTD interact with GAPDH-c. In contrast, the Y2HGold yeast strain cotransformed with GAPDH-c and p160 gag-pol did not grow on the QDO/X/A plates, despite sufficient protein expression levels, because the GAL4-activation domain (GAL4 AD) fused to p160 gag-pol could not translocate to the nucleus [16] . Although the p6 bait protein also indicated positive interaction with GAPDH-c, this result reflected its autoactivity, which was confirmed by transforming only the bait vector into Y2HGold in the absence of the prey vector ( Supplementary Fig. 1 ). These results suggest that MA and CA-NTD are essential for specific binding via the multiple-site binding of GAPDH to Pr55 gag . To explore the MA-or CA-NTD-interacting domain of GAPDH, we performed docking simulation of interaction between GAPDH (PDB ID: 1ZNQ) [17] and MA (PDB ID: 2H3I) [18] or CA (PDB ID: 1E6J) [19] with a software system molecular operating environment (MOE)-Dock (Docking software). The docking simulation proposed one possible model that the GAPDH helix 10 (255-267), which is located at the surface of GAPDH, plays a role in the interaction between GAPDH-c and MA or CA-NTD ( Fig. 2A) . Because GAPDH actually exists as a stable tetramer, which is in equilibrium with a metastable dimer, it is possible that GAPDH tetramer interacts with more than two proteins using same region. Therefore, on the basis of these deduced interaction domains, 5 single-point and 5 multiple-point mutants of the helix 10 domain of GAPDH were prepared to perform mutagenesis study (Fig. 2B) .
In Y2H analysis using GAPDH mutants and WT MA, as shown in the Fig. 3A , the K260E and Q264A of GAPDH mutants retained their ability to interact with WT MA. In contrast, the D256R, K263E or E267R of GAPDH mutants showed the loss of the ability to bind to WT MA. In addition, combined mutations except for D256R/K260E (M1) caused the loss of interaction. Western immunoblot analysis indicated that these effects were apparently not due to the low expression levels of the bait and prey proteins (Fig. 3B) Fig. 3C , the R58E, Q59A and Q63A
of MA mutants did not interact with GAPDH-c. These effects were also not due to the low protein expression levels of the bait and prey proteins (Fig. 3D ). These findings suggest that Asp
256
, Lys 263 and Glu 267 of GAPDH are crucial for the interaction between GAPDH and MA.
Since the docking simulation proposed that GAPDH helix 10 is also required for the interaction with CA-NTD, Y2H analysis focusing on the interaction GAPDH and CA-NTD was carried out. The D256R, K260E, K263E, Q264A and E267R of GAPDH single-point mutants maintained the interaction between GAPDH and CA-NTD (Fig. 3E) . In contrast, the multiple-point mutations of GAPDH, D256R/K260E (M1), D256R/ K260E/Q264A (M3) and D256R/K260E/Q264A/E267R (M5) lacked the binding ability to the WT CA-NTD. These results suggest that both of Asp 256 Fig. 3G , the E79R of CA-NTD mutant retained its ability to interact, but the E76R and R82E mutants lost their ability to interact with GAPDH-c. These effects were apparently not due to the low expression levels of the bait and prey proteins ( Fig. 3F and H (Fig. 4B, left panel) , despite the expression levels being sufficient for examining protein-protein interaction (Fig. 4B , right [14] . Therefore, V5-tagged WT or M6 GAPDH expression vectors were prepared and cotransfected into HEK293 cells with pNL-CH to investigate whether the viruses produced from M6-GAPDHexpressing cells showed suppressed GAPDH packaging and restored tRNA Lys3 packaging efficiency. We first performed coimmunoprecipitation assay to validate whether endogenous GAPDH and exogenous V5-tagged GAPDH retained oligomatic formation, because GAPDH exists primarily as a homotetramer in the cytoplasm [17] . The assay showed that both V5-tagged WT and M6 GAPDH retained oligomatic formation with endogenous GAPDH in HIV-1 producer cells (Fig. 4C) , suggesting that M6 did not affect the oligomatic formation of GAPDH. Furthermore, overexpression of V5-tagged WT GAPDH in HIV-1 producer cells (Fig. 4D , WT lane of producer cells) increased the endogenous and V5-tagged WT GAPDH incorporation levels in viruses (Fig. 4D , WT lane of viral particles) as previously described [14] . However, as expected, a similar level of expression of M6 GAPDH (Fig. 4D, M6 lane of producer cells) decreased the incorporation levels of both endogenous and V5-tagged M6 GAPDH (Fig. 4D, M6 lane of viral particles) in comparison with that of WT GAPDH. To address whether the decreased incorporation level of V5-tagged M6 GAPDH depended on the poorer interaction of GAPDH with Pr55 gag than V5-tagged WT GAPDH, we examined the interaction level in the virus producer cells by coimmunoprecipitation assay. As a result, the interaction between oligomatic GAPDH, which was composed of endogenous GAPDH and V5-tagged WT or M6 GAPDH, and Pr55 gag was found to be weaker in V5-tagged M6 GAPDH-expressing cells (Fig. 4E, M6 lane of IP) than in V5-tagged WT GAPDH-expressing cells (Fig. 4E, WT (Fig. 4F) . Furthermore, the levels of early reverse transcription products were also recovered by M6 GAPDH expression in virus producer cells (Fig. 4G) 
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HIV-1 replication.
Discussion
During HIV-1 assembly, the selective cellular tRNA Lys3 packaging is required for the effective reverse transcription [6] . Thus, the disruption of the interaction between the Pr55 gag /p160 important residues in the interaction of GAPDH with MA and CA-NTD. Importantly, the crystal structure of GAPDH tetramer (PDB ID: 1ZNQ) [17] shows that all of these amino acids in helix 10 are exposed on four each of monomer GAPDH, suggesting that two subunits of the GAPDH tetramer simultaneously interact with MA and CA-NTD, respectively (Supplementary Fig. 2A Fig. 2A ). Interestingly, a MOE candidate model ( Fig. 2A) /LysRS complex, the GAPDH tetramer efficiently suppresses the incorporation of tRNA Lys3 into the virions.
Taken together, these findings indicate that increasing the stability of the GAPDH tetramer or shifting the equilibrium toward the tetramer by increasing the expression level of GAPDH in HIV-1-infected cells might provide an effective approach to interrupt the tRNA Lys3 packaging into virions.
